Dose-intensified CHOP (double-CHOP) followed by consolidation with high-dose chemotherapy for high and high-intermediate risk aggressive non-Hodgkin's lymphomas

Leukemia and Lymphoma

Volumn 43, Issue 11, 2002, Pages 2117-2123

  Yamazaki, Tetsuo ^a   Sawada, Umihiko ^a   Kura, Yoshimasa ^a   Ito, Takeyoshi ^a   Kaneita, Yoshitaka ^a   Yasukawa, Kiyotaka ^a   Horie, Takashi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aggressive lymphoma; Double CHOP; High dose therapy; International prognostic index; Peripheral blood stem cell transplantation; Poor prognosis

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; METHOTREXATE; PREDNISONE; RANIMUSTINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE; ANTINEOPLASTIC AGENT; CHOP PROTOCOL;

ADULT; AGE; AGED; ARTICLE; BACTERIAL MENINGITIS; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; LEUKEMIA; MALE; MUCOSA INFLAMMATION; NEUTROPENIA; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; STEM CELL TRANSPLANTATION; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME; ADOLESCENT; MIDDLE AGED; MORTALITY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REMISSION; SURVIVAL;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; HUMANS; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PREDNISONE; PROGNOSIS; REMISSION INDUCTION; RISK ASSESSMENT; SURVIVAL ANALYSIS; VINCRISTINE;

EID: 0036838228     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819021000033033     Document Type: Article

References (20)

1. Fisher, R.I., Gaynor, E.R., Dahlberg, S., Oken, M.M., Grogan, T.M., Mize, E.M., Glick, J.H., Coltman, C.A., Jr. and Miller, T.P. (1993) "Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma", New England Journal Medicine 328, 1002-1006.
2. Shipp, M.A., Abeloff, M.D., Antman, K.H., Carroll, G., Hagenbeek, A., Loeffler, M., Montserrat, E., Radford, J.A., Salles, G., Schmitz, N., Symann, M., Armitage, J.O., Philip, T. and Coiffier, B. (1999) "International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive Non-Hodgkin's lymphoma: report of the jury", Journal of Clinical Oncology 17, 423-429.
3. The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) "A predictive model for aggressive non-Hodgkin's lymphoma", New England Journal Medicine 329, 987-993.
4. Haioun, C., Lepage, E., Gissellbrecht, C., Bastion, Y., Coiffier, B., Brice, P., Bosly, A., Dupriez, B., Nouvel, C., Tilly, H., Lederlin, P., Briere, J., Gaulard, P. and Reyes, F. (1997) "Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated result of the prospective study LNH87-2", Journal of Clinical Oncology 15, 1131-1137.
5. Nademanee, A., Molina, A., O'Donnell, M.R., Dagis, A., Snyder, D.S., Parker, P., Stein, A., Smith, E., Planas, I., Kashyap, A., Spielberger, R., Fung, H., Wong, K.K., Somlo, G., Margolin, K., Chow, W., Sniecinski, I., Vore, N., Blume, K.G., Niland, J. and Forman, S.J. (1997) "Result of high-dose therapy and autologous bone marrow stem cell transplantation during remission in poor-risk intermediate and high-grade lymphoma: international index high and high-intermediate risk group", Blood 90, 3844-3852.
6. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K.C., Cleary, M.L., Delsol, G., Wolf-Peeters, C.D., Falini, B., Gatter, K.C., Grogan, T.M., Isaacson, P.G., Knowles, D.M., Mason, D.Y, Muller-Harmelink, H., Pileri, S.A., Piris, M.A., Ralfkiaer, E. and Warnke, A. (1994) "A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group", Blood 84, 1361-1392.
7. Freedmen, A.S., Tacvorian, T., Neuberg, D., Mauch, P., Rabinowe, S.N., Anderson, K.C., Soiffer, R.J., Spector, N., Grossbard, M., Robertson, M.J., Blake, K., Coral, F., Canellos, G.P., Ritz, J. and Nadler, L.M. (1993) "Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B cell non-Hodgkin's lymphoma in first remission: a pilot study", Journal of Clinical Oncology 11, 931-936.
8. Waits, T.M., Greco, F.A., Greer, J.P., Johnson, D.H., Wolff, S.N., Stein, R.S., McMaster, M.L. and Hainsworth, J.D. (1999) "Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy", Journal of Clinical Oncology 11, 943-949.
9. Stoppa, A.M., Bouabdallah, R., Chabannon, C., Novakovitch, G., Vey, N., Camerlo, J., Blaise, D., Xerri, L., Resbeut, M., Di Stefano, D., Bardou, V.J., Gastaut, J.A. and Maraninchi, D. (1997) "Intensive sequential chemotherapy with repeated blood stem cell support for untreated poor-prognosis non-Hodgkin's lymphoma", Journal of Clinical Oncology 15, 1722-1729.
10. Stahel, R.A., Jost, L.M., Kroner, T., Dommann-Scherrer, C., Maurer, R., Glanzmann, C., Jacky, E., Pichert, G., Pestalozzi, B., Marincek, B., Sauter, C. and Honegger, H. (1999) "A prospective study of risk-adopted therapy for large cell non-Hodgkin's lymphoma with VACOP-B followed by high-dose CBV and autologous progenitor cell transplantation for high-risk patients in remission", British Journal of Haematology 104, 763-769.
11. Shipp, M.A., Neuberg, D., Janicek, M., Cancellos, G.P. and Shulman, L.N. (1995) "High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study", Journal of Clinical Oncology 13, 2916-2923.
12. Jauntnen, E., Mahlamaki, E. and Nousiainen, T. (2000) "Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (?60 years) with non-Hodgkin's lymphoma: comparison with patients <60 years treated within the same protocol", Bone Marrow Transplantation 26, 731-741.
13. Freedman, A., Neubelg, D., Mauch, P., Gribben, J., Soiffer, R., Anderson, K., Robertson, M., Fisher, D.C., Schlossman, R., Kroon, M., Rhuda, C., Kuhlman, C., Jerome, R. and Nadler, L. (1997) "Cyclophosphamide, doxorubicin, vincristine, prednisone dose intensification with granulocyte colony-stimulation factor markedly depletes stem cell reserve for autologous bone marrow transplantation", Blood 90, 4996-5001.
14. Santini, G., Salvagno, L., Leoni, P., Chisesi, T., De Souza, C., Sertoli, M.R., Rubagotti, A., Congiu, A.M., Centurioni, R., Olivieri, A., Tedeschi, L., Vespignani, M., Nati, S., Soracco, M., Porcellini, A., Contu, A., Guarnaccia, C., Pescosta, N., Majolino, I., Spriano, M., Vimercati, R., Rossi, E., Zambaldi, G., Mangoni, L., Endrizzi, L., Sileni, V.C., Miggiano, M.C., Marino, G., Damasio, E. and Rizzoli, V. (1998) "VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the Non-Hodgkin's Lymphoma Cooperative Study Group", Journal of Clinical Oncology 16, 2796-2802.
15. Dumontet, C., Thieblemont, C., Epinouse, D., Bouafia, F., Hequet, O., Salles, G. and Coiffier, B. (2000) "A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin's lymphoma and two or three adverse prognostic factors", Leukemia 14, 2159-2165.
16. Bouabdallah, R., Stoppa, A.M., Coso, D., Bardou, V.J., Blaise, D., Chabannon, C., Gastaut, J.A. and Maraninchi, D. (2001) "Clinical outcome after front-line intensive chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI3): final analysis of survival in two consecutive ISC trials", Annals of Oncology 12, 513-517.
17. For the Non-Hodgkin's lymphoma classification project Armitage, J.O. and Weisenburger, D.D. (1998) "New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes", Journal of Clinical Oncology 16, 1780-1795.
18. Moreau, P., Milpied, N., Voillat, L., Colombat, P., Mahe, B., Rapp, M.J., Moreau, A., Dupas, B., Bulabois, C.E., Jude-Morineau, N. and Harousseau, J.L. (1998) "Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study", Bone Marrow Transplantarion 21, 1193-1196.
19. Krishman, A., Bhatia, S., Slovak, M.L., Arber, D.A., Niland, J.C., Nademanee, A., Fung, H., Bhatia, R., Kashyap, P., Molina, A., O'Donnell, M.R., Parker, P.A., Sniecinski, I., Snyder, D.S., Spielberger, R., Stein, A. and Forman, S.J. (2000) "Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors", Blood 95, 1588-1593.
20. Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., Reyes, F., Lederlin, P. and Gisselbrecht, C. (2002) "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma", New England Journal of Medicine